William H. Mcbride

William H. Mcbride's AcademicInfluence.com Rankings

William H. Mcbride

Philosophy

#6892

World Rank

#10009

Historical Rank

Logic

#3984

World Rank

#5223

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is William H. Mcbride Influential?

(Suggest an Edit or Addition)

(See a Problem?)

William H. Mcbride's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. (2006) (1385)
Effects of radiation on normal tissue: consequences and mechanisms. (2003) (808)
Maximizing tumor immunity with fractionated radiation. (2012) (442)
IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. (1989) (422)
Animal Models for Medical Countermeasures to Radiation Exposure (2010) (351)
Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells. (2006) (351)
Induction of acute phase gene expression by brain irradiation. (1995) (338)
Combining radiotherapy and immunotherapy: a revived partnership. (2005) (337)
A comparison of gene transfer methods in human dendritic cells. (1997) (333)
Opportunities and challenges of radiotherapy for treating cancer (2015) (319)
Radiation enhances regulatory T cell representation. (2011) (319)
Cytokines in Radiobiological Responses: A Review (2012) (296)
Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanoma. (2003) (267)
In vivo imaging, tracking, and targeting of cancer stem cells. (2009) (263)
Models for Evaluating Agents Intended for the Prophylaxis, Mitigation and Treatment of Radiation Injuries Report of an NCI Workshop, December 3–4, 2003 (2004) (253)
Macrophages from irradiated tumors express higher levels of iNOS, arginase-I and COX-2, and promote tumor growth. (2007) (206)
A Sense of Danger from Radiation1 (2004) (198)
Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells. (1997) (194)
The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells. (2002) (191)
Hyaluronidase-sensitive halos around adherent cells. Their role in blocking lymphocyte-mediated cytolysis (1979) (190)
A Phase I/II Trial Testing Immunization of Hepatocellular Carcinoma Patients with Dendritic Cells Pulsed with Four α-Fetoprotein Peptides (2006) (184)
Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein. (1999) (170)
Drug affinity responsive target stability (DARTS) for small-molecule target identification. (2015) (169)
Ionizing radiation activates the Nrf2 antioxidant response. (2010) (169)
Radiation-induced astrocytic and microglial responses in mouse brain. (1993) (166)
T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancer. (2003) (166)
Rapid induction of cytokine gene expression in the lung after single and fractionated doses of radiation. (1999) (166)
Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirus. (1998) (164)
Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer (2018) (163)
Delayed molecular responses to brain irradiation. (1997) (162)
Radiation and inflammation. (2015) (161)
The Combination of Ionizing Radiation and Peripheral Vaccination Produces Long-term Survival of Mice Bearing Established Invasive GL261 Gliomas (2006) (152)
The Confluence of Stereotactic Ablative Radiotherapy and Tumor Immunology (2011) (151)
Molecular advances in pretargeting radioimunotherapy with bispecific antibodies. (2002) (149)
A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides. (2006) (133)
α-Fetoprotein-specific Genetic Immunotherapy for Hepatocellular Carcinoma (1999) (133)
Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells. (2000) (131)
Adenovirus-based transfer of wild-type p53 gene increases ovarian tumor radiosensitivity. (1996) (130)
Molecular mechanisms of late normal tissue injury. (2007) (123)
T Cell Responses to HLA-A*0201-Restricted Peptides Derived from Human α Fetoprotein1 (2001) (120)
Role of Dendritic Cell Phenotype, Determinant Spreading, and Negative Costimulatory Blockade in Dendritic Cell-Based Melanoma Immunotherapy (2004) (118)
Genetic modification of a murine fibrosarcoma to produce interleukin 7 stimulates host cell infiltration and tumor immunity. (1992) (116)
Ionizing Radiation Affects Human MART-1 Melanoma Antigen Processing and Presentation by Dendritic Cells1 (2004) (114)
Phenotype and functions of intratumoral macrophages. (1986) (114)
Radiotherapy Decreases Vascular Density and Causes Hypoxia with Macrophage Aggregation in TRAMP-C1 Prostate Tumors (2009) (114)
Molecular response to cetuximab and efficacy of preoperative cetuximab-based chemoradiation in rectal cancer. (2009) (111)
Links between Innate Immunity and Normal Tissue Radiobiology (2010) (111)
Genetic analysis of the human tumor necrosis factor alpha/cachectin promoter region in a macrophage cell line (1989) (109)
Compartmental responses after thoracic irradiation of mice: strain differences. (2005) (107)
p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma. (1999) (106)
alpha-Fetoprotein-specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccination. (2001) (103)
After the bomb drops: A new look at radiation-induced multiple organ dysfunction syndrome (MODS) (2011) (103)
Radiosensitivity of ataxia-telangiectasia, X-linked agammaglobulinemia, and related syndromes using a modified colony survival assay. (1994) (103)
Inhibition of NF-κB, Clonogenicity, and Radiosensitivity of Human Cancer Cells (1999) (102)
T-Cell Responses to Survivin in Cancer Patients Undergoing Radiation Therapy (2008) (99)
In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vector. (1996) (97)
Ionizing radiation affects 26s proteasome function and associated molecular responses, even at low doses. (2001) (96)
Radiation enhances tumor necrosis factor α production by murine brain cells (1991) (92)
Apoptosis and radiosensitization of hodgkin cells by proteasome inhibition. (2000) (92)
Decreased growth of human prostate LNCaP tumors in SCID mice fed a low-fat, soy protein diet with isoflavones. (1999) (90)
Comparison of the gastrointestinal syndrome after total-body or total-abdominal irradiation. (1989) (86)
In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2. (1997) (86)
Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma. (1999) (83)
Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccines. (1993) (82)
T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein. (2001) (81)
Biologically effective dose distribution based on the linear quadratic model and its clinical relevance (1995) (81)
Effects of recombinant erythropoietin on breast cancer-initiating cells. (2007) (80)
Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers. (2006) (80)
Animal Models for Radiation Injury, Protection and Therapy (2005) (79)
The role of tumor necrosis factor signaling pathways in the response of murine brain to irradiation. (2001) (76)
The Proteasome in Cancer Biology and Treatment (2001) (75)
Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cells. (2000) (75)
Assay of radiation effects in mouse skin as expressed in wound healing. (1988) (73)
Regulatory T Cells in Radiotherapeutic Responses (2012) (73)
Molecular Pathways That Modify Tumor Radiation Response (2001) (71)
In vivo trafficking of adoptively transferred interleukin-2 expanded tumor-infiltrating lymphocytes and peripheral blood lymphocytes. Results of a double gene marking trial. (1996) (70)
Modifying Normal Tissue Damage Postirradiation (2002) (67)
Immunosensitization of Tumor Cells to Dendritic Cell-Activated Immune Responses with the Proteasome Inhibitor Bortezomib (PS-341, Velcade)1 (2006) (67)
Human Dendritic Cell Maturation by Adenovirus Transduction Enhances Tumor Antigen-Specific T-Cell Responses (2004) (66)
T lymphocytes and normal tissue responses to radiation (2012) (64)
Bronchoalveolar lavage and interstitial cells have different roles in radiation-induced lung injury (2003) (62)
High-Throughput Screening Identifies Two Classes of Antibiotics as Radioprotectors: Tetracyclines and Fluoroquinolones (2009) (62)
Enhancement of tumor radioresponse by docetaxel: Involvement of immune system. (2001) (60)
The effect of local and systemic irradiation on impairment of wound healing in mice. (1993) (59)
Tumour necrosis factor production by IL-2-activated macrophages in vitro and in vivo. (1989) (59)
N-acetyl-L-cysteine inhibits 26S proteasome function: implications for effects on NF-κB activation (2002) (59)
The biological effectiveness of antiproton irradiation. (2006) (59)
Hyperthermia-induced proteasome inhibition and loss of androgen receptor expression in human prostate cancer cells. (2005) (58)
Tumour growth, phagocytic activity and antibody response in Corynebacterium parvum-treated mice. (1974) (58)
Double blind randomized phase II study with radiation+5-fluorouracil+/-celecoxib for resectable rectal cancer. (2009) (57)
Interleukin‐4 Downregulates Interleukin‐6 Production in Human Peripheral Blood Mononuclear Cells (1990) (57)
Protective Properties of Radio-Chemoresistant Glioblastoma Stem Cell Clones Are Associated with Metabolic Adaptation to Reduced Glucose Dependence (2013) (56)
Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human alpha-fetoprotein. (2000) (56)
HDJ-2 as a target for radiosensitization of glioblastoma multiforme cells by the farnesyltransferase inhibitor R115777 and the role of the p53/p21 pathway. (2006) (55)
Biologically effective dose distribution based on the linear quadratic model and its clinical relevance. (1995) (55)
Tumor necrosis factor-alpha plays a central role in interleukin-2-induced pulmonary vascular leak and lymphocyte accumulation. (1994) (53)
Development of new multivalent-bispecific agents for pretargeting tumor localization and therapy. (2003) (53)
The effects of tea extracts on proinflammatory signaling (2006) (52)
Immunosuppression by melanoma cells as a factor in the generation of metastatic disease. (1989) (51)
Transduction of human melanoma cell lines with the human interleukin-7 gene using retroviral-mediated gene transfer: comparison of immunologic properties with interleukin-2. (1993) (51)
CD40 cross-linking bypasses the absolute requirement for CD4 T cells during immunization with melanoma antigen gene-modified dendritic cells. (2001) (51)
Cytokine cascades in late normal tissue radiation responses. (1995) (51)
Anthracyclines, proteasome activity and multi-drug-resistance (2005) (50)
Pretargeting of Carcinoembryonic Antigen–Expressing Cancers with a Trivalent Bispecific Fusion Protein Produced in Myeloma Cells (2005) (49)
Influences of interleukins 2 and 4 on tumor necrosis factor production by murine mononuclear phagocytes. (1990) (47)
Inhibition of NF-kappaB, clonogenicity, and radiosensitivity of human cancer cells. (1999) (47)
Generation of intestinal mucosal lymphocytes in SCID mice reconstituted with mature, thymus-derived T cells. (1998) (46)
Lymphocyte subset alterations in nodes regional to human melanoma. (1990) (46)
Production of 13-hydroxyoctadecadienoic acid and tumor necrosis factor-alpha by murine peritoneal macrophages in response to irradiation. (1994) (45)
Immune Response to a Soluble Protein Antigen in NZB Mice (1968) (45)
Protection against Radiation-Induced Bone Marrow and Intestinal Injuries by Cordyceps sinensis, a Chinese Herbal Medicine (2006) (45)
Characterization of antitumor immunization to a defined melanoma antigen using genetically engineered murine dendritic cells (1999) (44)
Cutaneous wound healing through paradoxical MAPK activation by BRAF inhibitors (2016) (44)
Activation of the classical and alternate pathways of complement by Corynebacterium parvum. (1975) (44)
Pleiotrophin mediates hematopoietic regeneration via activation of RAS. (2014) (44)
Functional phenotype of macrophages depends on assay procedures. (2008) (44)
NF-kappa B, cytokines, proteasomes, and low-dose radiation exposure. (2002) (43)
The proteasome inhibitor MG-132 sensitizes PC-3 prostate cancer cells to ionizing radiation by a DNA-PK-independent mechanism (2005) (43)
Immune deviation and Fas-mediated deletion limit antitumor activity after multiple dendritic cell vaccinations in mice. (2000) (43)
Prostratin and Bortezomib are Novel Inducers of Latent Kaposi'S Sarcoma-Associated Herpesvirus (2005) (42)
Modification of the tumor microenvironment to enhance immunity. (2007) (42)
Effect of interleukin 1, inflammation, and surgery on the incidence of adhesion formation and death after abdominal irradiation in mice. (1989) (42)
Prediction of poor survival by cyclooxygenase‐2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: Clinical and in vitro studies (2005) (41)
Down-regulation of murine fibrosarcoma transforming growth factor-beta 1 expression by interleukin 7. (1995) (40)
Effect of fibroblast implants on wound healing of irradiated skin: assay of wound strength and quantitative immunohistology of collagen. (1991) (40)
Induction of tolerance to a murine fibrosarcoma in two zones of dosage--the involvement of suppressor cells. (1986) (40)
Lymphatic Fistulas: Obliteration by Low-Dose Radiotherapy (2005) (40)
SOCS3 regulates p21 expression and cell cycle arrest in response to DNA damage. (2008) (39)
Radiation‐induced tissue damage and response (2020) (39)
Myelin-associated changes in mouse brain following irradiation. (1993) (39)
Radioimmunotherapy: Is avidin-biotin pretargeting the preferred choice among pretargeting methods? (2003) (39)
Combining radiation therapy with interleukin-3 gene immunotherapy (2000) (38)
Radioprotective effects of Bmi-1 involve epigenetic silencing of oxidase genes and enhanced DNA repair in normal human keratinocytes. (2011) (38)
National Institutes of Health funding in radiation oncology: a snapshot. (2013) (38)
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks? (2020) (38)
The effect of single doses of radiation on mouse spinal cord. (1992) (38)
Molecular and clinico-pathological markers in rectal cancer: a tissue micro-array study (2009) (38)
Adenovirus-mediated gene transfer in the transplant setting. I. Conditions for expression of transferred genes in cold-preserved hepatocytes. (1994) (38)
Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells. (2000) (37)
Spinal cord tolerance to single-fraction partial-volume irradiation: a swine model. (2011) (37)
Modulation of human macrophage functions by gangliosides. (1989) (35)
Can short-term administration of dexamethasone abrogate radiation-induced acute cytokine gene response in lung and modify subsequent molecular responses? (2001) (35)
Spinal cord tolerance to reirradiation with single-fraction radiosurgery: a swine model. (2012) (35)
Defined Sensing Mechanisms and Signaling Pathways Contribute to the Global Inflammatory Gene Expression Output Elicited by Ionizing Radiation. (2017) (35)
The activation state of macrophage subpopulations from a murine fibrosarcoma (1980) (35)
Marrow-Derived Stromal Cell Delivery on Fibrin Microbeads Can Correct Radiation-Induced Wound Healing Deficits (2012) (35)
Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide (2015) (34)
Natural killer cells play a critical role in the immune response following immunization with melanoma-antigen-engineered dendritic cells (2005) (34)
Effect of Macrophage-Derived Apolipoprotein E on Established Atherosclerosis in Apolipoprotein E–Deficient Mice (2000) (32)
T cell receptor (TCR)-transgenic CD8 lymphocytes rendered insensitive to transforming growth factor beta (TGFβ) signaling mediate superior tumor regression in an animal model of adoptive cell therapy (2012) (32)
High throughput screening of small molecule libraries for modifiers of radiation responses (2011) (32)
Radiation enhances tumor necrosis factor alpha production by murine brain cells. (1991) (32)
Radio-sensitization of gliomas by intracellular generation of 5-fluorouracil potentiates prodrug activator gene therapy with a retroviral replicating vector (2014) (31)
The Effect of Interleukin-1β or Transforming Growth Factor-β on Radiation-Impaired Murine Skin Wound Healing (1995) (31)
G2/M-phase arrest and release in ataxia telangiectasia and normal cells after exposure to ionizing radiation. (1994) (31)
Effects of IL-3 gene expression on tumor response to irradiation in vitro and in vivo. (1997) (31)
FLT-PET Imaging of Radiation Responses in Murine Tumors (2008) (30)
Education and Training for Radiation Scientists: Radiation Research Program and American Society of Therapeutic Radiology and Oncology Workshop, Bethesda, Maryland, May 12–14, 2003 (2003) (30)
Integration of Epidermal Growth Factor Receptor Inhibitors with Preoperative Chemoradiation (2010) (30)
Dendritic Cell–Based Immunotherapy in Prevention and Treatment of Renal Cell Carcinoma: Efficacy, Safety, and Activity of Ad-GM·CAIX in Immunocompetent Mouse Models (2013) (30)
Increased phagocytic cell activity and anaemia in Corynebacterium parvum treated mice. (1974) (30)
Cellular interactions in thymus-dependent antibody responses. (1982) (30)
Single-dose compared with fractionated-dose radiation of the OM431 choroidal melanoma cell line. (1995) (30)
Interleukin-7 gene transfer in non-small-cell lung cancer decreases tumor proliferation, modifies cell surface molecule expression, and enhances antitumor reactivity. (1996) (29)
Baseline T cell dysfunction by single cell network profiling in metastatic breast cancer patients (2019) (29)
Biological effectiveness of antiproton annihilation (2004) (29)
c-Abl is required for development and optimal cell proliferation in the context of p53 deficiency. (2000) (28)
Enhanced Tumor Responses to Dendritic Cells in the Absence of CD8-Positive Cells1 (2004) (28)
Morphological features and molecular markers in rectal cancer from 95 patients included in the European Organisation for Research and Treatment of Cancer 22921 trial: prognostic value and effects of preoperative radio (chemo) therapy. (2008) (28)
Induction of c-fos and junB mRNA following in vivo brain irradiation. (1997) (28)
The extent, time course, and fraction size dependence of mouse spinal cord recovery from radiation injury. (1994) (28)
The effect of gold salts on tumour immunity and its stimulation by Corynebacterium Parvum. (1975) (28)
Growth factors: biological and clinical aspects. (1999) (28)
Interleukin-3 in gene therapy of cancer. (1994) (27)
Sensitization of renal carcinoma to radiation using alpha interferon (IFNA) gene transfection. (1997) (27)
Current status and recommendations for the future of research, teaching, and testing in the biological sciences of radiation oncology: report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, executive summary. (2014) (27)
A comparative study of anaerobic Coryneforms. Attempts to correlate their anti-tumour activity with their serological properties and ability to stimulate the lymphoreticular system. (1975) (27)
Differential Effects of the Proteasome Inhibitor NPI-0052 against Glioma Cells. (2010) (26)
Proteasome Structures Affected by Ionizing Radiation (2005) (26)
Alteration in myelin-associated proteins following spinal cord irradiation in guinea pigs. (1992) (25)
Image guidance during head-and-neck cancer radiation therapy: analysis of alignment trends with in-room cone-beam computed tomography scans. (2012) (25)
Properties of an Antigenic Polysaccharide from Corynebacterium parvum (1974) (25)
Factors influencing the immune response. II. Effects of the physical state of the antigen and of lymphoreticular cell proliferation on the response to intraperitoneal injection of bovine serum albumin in rabbits. (1967) (25)
Cordyceps sinensis Health Supplement Enhances Recovery from Taxol-Induced Leukopenia (2008) (25)
Adenoviral interleukin-3 gene-radiation therapy for prostate cancer in mouse model. (2004) (24)
Counteracting tumor radioresistance by targeting DNA repair (2005) (23)
Apoptosis and delayed expression of c-jun and c-fos after gamma irradiation of Jurkat T cells. (1996) (23)
Antitumor protection using murine dendritic cells pulsed with acid-eluted peptides from in vivo grown tumors of different immunogenicities. (1999) (23)
Epidermal Growth Factor Receptor vIII Expression in U87 Glioblastoma Cells Alters Their Proteasome Composition, Function, and Response to Irradiation (2008) (23)
The effect of hyperfractionation on spinal cord response to radiation. (1992) (22)
Simultaneous use of two retroviral vectors in human gene marking trials: feasibility and potential applications. (1992) (22)
Adhesion formation in experimental chronic radiation enteropathy. (1989) (22)
The effect of fractionated doses of radiation on mouse spinal cord. (1993) (22)
Insulin-like growth factor-type 1 receptor inhibitor NVP-AEW541 enhances radiosensitivity of PTEN wild-type but not PTEN-deficient human prostate cancer cells. (2011) (22)
Identification of miRNA signatures associated with radiation-induced late lung injury in mice (2020) (21)
Effects of gamma radiation on the OM431 human ocular melanoma cell line. (1995) (21)
Antiangiogenic effects of noscapine enhance radioresponse for GL261 tumors. (2008) (21)
Interleukin-6 production by human melanoma cell lines. (1992) (21)
Plasticity of Myeloid Cells during Oral Barrier Wound Healing and the Development of Bisphosphonate-related Osteonecrosis of the Jaw* (2016) (21)
Fibrin microbeads loaded with mesenchymal cells support their long-term survival while sealed at room temperature. (2011) (20)
Radiation-induced apoptosis and cell cycle progression in Jurkat T cells. (1999) (20)
MEETING REPORT Modifying Normal Tissue Damage Postirradiation Report of a Workshop Sponsored by the Radiation Research Program (2002) (19)
In vivo transfer of antitumor activity by peritoneal exudate cells from mice treated with Corynebacterium parvum: reduced effect in irradiated recipients. (1977) (19)
Spinal cord tolerance to single-session uniform irradiation in pigs: implications for a dose-volume effect. (2013) (19)
Modifying radiation damage. (2010) (19)
The in vitro killing of syngeneic cells by peritoneal cells from adjuvant-stimulated mice. (1975) (19)
Adriamycin-induced recall of radiation pneumonitis and epilation in lung and hair follicles of mouse. (1992) (18)
In vitro and in vivo evaluation of the radiosensitizing effect of a selective FGFR inhibitor (JNJ-42756493) for rectal cancer (2015) (18)
Screening of antimicrobial agents for in vitro radiation protection and mitigation capacity, including those used in supportive care regimens for bone marrow transplant recipients. (2010) (18)
Are We Ready for a Radiological Terrorist Attack Yet? Report From the Centers for Medical Countermeasures Against Radiation Network. (2015) (18)
Factors influencing the immune response. 3. The blocking effect of Corynebacterium parvum upon the induction of acquired immunological unresponsiveness to bovine serum albumin in the adult rabbit. (1968) (18)
5-aminoimidazole-4-carboxamide riboside enhances effect of ionizing radiation in PC3 prostate cancer cells. (2011) (17)
Cyclophosphamide‐Induced Alterations in Human Monocyte Functions (1987) (17)
Enhancement of lung colony-forming efficiency by local thoracic irradiation: interpretation of labeled cell studies. (1978) (17)
T Cell Responses to HLA-A*0201-Restricted Peptides Derived from Human a Fetoprotein (2001) (17)
Antitumor antibodies and immunoglobulin class and subclass levels in Corynebacterium parvum-treated mice. (1976) (16)
Radiation Biology in the Context of Changing Patterns of Radiotherapy (2014) (16)
The effects of cytokine gene transfer into tumors on host cell infiltration and regression. (1996) (16)
PTPσ inhibitors promote hematopoietic stem cell regeneration (2019) (16)
The Effect of Intravenous and Intramuscular Injection of Corynebacterium parvum (1975) (16)
The effect of Corynebacterium parvum therapy on immunoglobulin class and IgG subclass levels in cancer patients. (1975) (16)
Adjuvant-induced antired blood cell activity in CBA mice. (1971) (16)
Modification of tumor microenvironment by cytokine gene transfer. (1995) (15)
N-acetyl-L-cysteine inhibits 26S proteasome function: implications for effects on NF-kappaB activation. (2002) (15)
Survival of AIDS patients with primary central nervous system lymphoma may be improved by the radiosensitizing effects of highly active antiretroviral therapy. (2002) (15)
Factors influencing the immune response. I. Effects of the physical state of the antigen and of lymphoreticular cell proliferation on the response to intravenous injection of bovine serum albumin in rabbits. (1967) (15)
Production of tumor necrosis factor α and interferon γ in interleukin-2-treated melanoma patients: Correlation with clinical toxicity (2005) (15)
Immunosuppressive effects of interleukin-12 coexpression in melanoma antigen gene–modified dendritic cell vaccines (2002) (15)
Small lipidated anti-obesity compounds derived from neuromedin U. (2015) (15)
Role of the thymus in radiation-induced lung damage after bone marrow transplantation. (1997) (15)
Postoperative irradiation impairs or enhances wound strength depending on time of administration. (1995) (15)
Abstract 633: Inhibition of TGFβ as a strategy to convert the irradiated tumor into in situ individualized vaccine (2014) (14)
Preparing for the future of radiation oncology. (2007) (14)
Defenses against Pro-oxidant Forces - Maintenance of Cellular and Genomic Integrity and Longevity (2018) (14)
The effect of interleukin-1 beta or transforming growth factor-beta on radiation-impaired murine skin wound healing. (1995) (14)
A novel modular polymer platform for the treatment of head and neck squamous cell carcinoma in an animal model. (2012) (14)
Morphology of hyaluronidase-sensitive cell coats as seen in the SEM after freeze-drying. (1983) (14)
The proteasome inhibitor MG-132 protects hypoxic SiHa cervical carcinoma cells after cyclic hypoxia/reoxygenation from ionizing radiation. (2006) (14)
4-(Nitrophenylsulfonyl)piperazines mitigate radiation damage to multiple tissues (2017) (14)
Small Azurin Derived Peptide Targets Ephrin Receptors for Radiotherapy (2011) (14)
Accessory cell activity of murine tumor-associated macrophages. (1986) (13)
Tumor Size Matters—Understanding Concomitant Tumor Immunity in the Context of Hypofractionated Radiotherapy with Immunotherapy (2020) (13)
Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation- and cyclophosphamide-induced attenuation in antitumor resistance. (1984) (13)
In vitro autoradiography of carcinoembryonic antigen in tissue from patients with colorectal cancer using multifunctional antibody TF2 and (67/68Ga)-labeled haptens by pretargeting. (2012) (13)
Effect of nicotinamide and pentoxifylline on normal tissue and FSA tumor oxygenation. (1995) (12)
Active Combination Therapy of Bortezomib (Velcade) and Ibritumomab Tiuxetan (Zevalin) in an In Vivo Diffuse Large B-Cell Lymphoma Model. (2005) (12)
Production of tumor necrosis factor alpha and interferon gamma in interleukin-2-treated melanoma patients: correlation with clinical toxicity. (1991) (12)
Intratumoral interleukin-2 immunotherapy: Activation of tumor-infiltrating and splenic lymphocytes in vivo (2005) (12)
A role for T lymphocytes in tumour inhibition and enhancement caused by systemic administration of Corynebacterium parvum. (1978) (12)
The Aftermath of Surviving Acute Radiation Hematopoietic Syndrome and its Mitigation (2019) (12)
Irradiation to Improve the Response to Immunotherapeutic Agents in Glioblastomas (2018) (11)
Flying by the seat of our pants: is low dose radiation therapy for COVID-19 an option? (2020) (11)
Factors affecting tumor 18 F-FDG uptake in longitudinal mouse PET studies (2013) (11)
Macrophage heterogeneity. (1984) (10)
Differential effects of granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor on tumor necrosis factor and interleukin-1 production in human monocytes. (1990) (10)
Antitumor activity of Corynebacterium parvum extracts. (1976) (9)
Paradoxical presence of T cell anergy during successful T cell-dependent tumour immunotherapy: characterization of a state of T cell 'amnaesia' following systemic administration of C. parvum. (1984) (9)
FAILLA MEMORIAL LECTURE A Sense of Danger from Radiation 1 (2004) (9)
A perspective on the impact of radiation therapy on the immune rheostat (2017) (9)
Changes in Imaging and Cognition in Juvenile Rats After Whole-Brain Irradiation (2016) (9)
Time‐Dependent Measurement of Nrf2‐Regulated Antioxidant Response to Ionizing Radiation Toward Identifying Potential Protein Biomarkers for Acute Radiation Injury (2019) (9)
Novel dimeric Smac analogs as prospective anticancer agents. (2014) (9)
Role of macrophage-colony-stimulating factor in regulating the accumulation and phenotype of tumor-associated macrophages (1997) (9)
Grouping of beta-haemolytic streptococci by enzyme-linked immunosorbent assay. (1980) (9)
Interleukin 32 expression in human melanoma (2019) (8)
Broad antitumor protection by dendritic cells administered to CD8α knock out mice (2006) (8)
Interaction of tumor cells and activated macrophages in vitro: modulation by Corynebacterium parvum and gold salt. (1976) (8)
Effects of Corynebacterium parvum on Immunological Unresponsiveness to Bovine Serum Albumin in the Rabbit (1967) (8)
Postirradiation protection of chromosomes by linoleate. (1988) (8)
1-(4-nitrobenzenesulfonyl)-4-penylpiperazine increases the number of Peyer's patch-associated regenerating crypts in the small intestines after radiation injury. (2019) (7)
Inhibitory effect of locally produced and exogenous interleukin-6 on tumor growth in vivo (1994) (7)
Immunoregulating activity of tumor-associated macrophages (2004) (7)
Phase I clinical study of the feasibility of pretargeted radioimmunotherapy (PT-RAIT) in patients with colorectal cancer (CRC): First results (2011) (7)
T cell receptor transgenic lymphocytes infiltrating murine tumors are not induced to express foxp3 (2011) (7)
Molecular mechanisms regulating TNF-alpha production by tumor-associated macrophages. (1997) (7)
Tumour Immunity in Prognosis: the role of mononuclear cell infiltration (1983) (7)
Bridged Analogues for p53-Dependent Cancer Therapy Obtained by S-Alkylation (2016) (7)
Effect of C. parvum on the number and activity of macrophages in primary and transplanted murine fibrosarcomas. (1982) (7)
Are animal models a necessity for acute radiation syndrome drug discovery? (2019) (6)
Pitfalls in the use of the lung colony assay to assess T-cell function in irradiated mice. (1977) (6)
The treatment of patients with metastatic melanoma and renal cell cancer using in vitro expanded and genetically-engineered (neomycin phosphotransferase) bulk, CD8(+) and/or CD4(+) tumor infiltrating lymphocytes and bulk, CD8(+) and/or CD4(+) peripheral blood leukocytes in combination with recombina (1992) (6)
Effect of low-dose radiation on mouse dermal tissue using wound strength as an endpoint. (1997) (6)
Analysis of anaerobic coryneform cell wall antigens by radioimmunoassay. (1975) (6)
A fork in the road: choosing the path of relevance. (2015) (6)
Enhanced Fc receptor expression by a sub-population of murine intra-tumour macrophages following intravenous Corynebacterium parvum therapy. (1983) (6)
In situ Tumor Ablation with Radiation Therapy: Its Effect on the Tumor Microenvironment and Anti-tumor Immunity (2013) (6)
Integration of adenovirus thymidine kinase suicide-gene therapy with surgery and radiation therapy for malignant glioma. (2012) (5)
Molecular and celluar responses of the brain to radiotherapy (1997) (5)
Inhibition of NFk B , Clonogenicity , and Radiosensitivity of Human Cancer Cells (1999) (5)
Prediction of pathological response to preoperative chemoradiotherapy with cetuximab in rectal cancer (2008) (5)
Concomitant development of granulocytosis and enhancement of metastases formation in tumor-bearing mice (1984) (5)
Imaging of radiation effects on cellular 26S proteasome function in situ (2009) (5)
Relative Biological Effectiveness and Peripheral Damage of Antiproton Annihilation (2002) (5)
TUMOR-DIRECTED CYTOKINE GENE THERAPY (1994) (5)
Immune rejection in a humanized model of murine prostate cancer. (2010) (5)
Radiation Effects on Normal Tissues (1999) (5)
The effect of C. parvum therapy on intratumoral macrophage subpopulations. (1982) (5)
Distribution of IgM, IgA and IgG secreting cells in the tissues of normal and tumour-bearing mice. (1982) (5)
Molecular mechanisms regulating TNF-α production by tumor-associated macrophages (1997) (4)
A role for T lymphocytes in the antitumour action of systemic C. parvum. (1977) (4)
Are 'new' antigenic determinants exposed on aggregated bovine serum albumin? (1980) (4)
Further studies on antitumour responses induced by short-term pretreatment with syngeneic tumour cells. (1979) (4)
Selective and Nonselective Replication of an E 1 B-deleted Adenovirus in Hepatocellular Carcinoma 1 (1999) (4)
Effect of hyperfractionation on spinal cord tolerance (1991) (4)
Complications in the functional analysis of transfected MHC genes. (1994) (3)
Induction of early response genes and tumor necrosis factor (TNF) by irradiation does not appear to occur through map kinase pathway in HL-60 cells (1994) (3)
Subverting misconceptions about radiation therapy (2016) (3)
Radiation Protection and Cancer Therapy by Linoleate (1991) (3)
Molecular mechanisms of interleukin 2 induction of tumor necrosis factor gene expression in macrophages (1988) (3)
Mechanisms mediating the effects of IL‐3 gene expression on tumor growth (2000) (3)
Ionizing radiation affects tumor antigen presentation by dendritic cells (2003) (3)
Molecular Mechanisms of Radiotherapy (2005) (3)
Radiation & Inflammation (2015) (3)
Combining Radiation Therapy with Immunotherapy for Treatment of Brain Tumors (2001) (3)
The Human Immunodeficiency Virus ( HIV )-1 Protease Inhibitor Saquinavir Inhibits Proteasome Function and Causes Apoptosis and Radiosensitization in Non-HIV-associated Human Cancer Cells 1 (2002) (3)
If It Seems Too Good to Be True…. (2019) (2)
Tumor-associated immunoglobulins, antitumor antibodies, and antiviral antibodies in C. parvum-treated normal and tumor-bearing mice (1978) (2)
The origins of translational radiation oncology - In memoriam H. Rodney Withers (21 September 1932-25 February 2015). (2015) (2)
Serological changes associated with C. parvum treatment in nude mice. (1977) (2)
Mycoplasmas and 'diphtheroids' in rheumatoid arthritis. (1975) (2)
QUALITY OF LIFE/AFTERCARE (2012) (2)
Lipid-conjugated Smac analogues. (2015) (2)
Hyperfractionation: The offsetting effects of decreased fraction size and decreased interfraction interval on spinal cord tolerance (1993) (2)
Interleukin-4: A potent inhibitor of IL-6, TNF-α, IFN-γ, and IL-1β production (1990) (2)
Transduction of murine and human tumors using recombinant adenovirus vectors (2006) (2)
Prognostic indicators in node-negative breast cancer. (1990) (2)
HDJ-2 is an important target of farnesyltransferase inhibitor, R115777, induced radiosensitization (2005) (2)
In vivo transfer of antitumor activity by peritoneal exudate cells from mice treated with C. parvum. (1977) (2)
Cellular effects of radiotherapy for benign disease. (2001) (2)
EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY (2013) (2)
Gene therapy-based approaches to the treatment of cancer: Development of targetable retroviral vectors (1996) (2)
Presentation by Dendritic Cells Melanoma Antigen Processing and Ionizing Radiation Affects Human MART-1 (2013) (2)
In Memoriam: H. Rodney Withers (21 September 1932–25 February 2015) (2015) (2)
Classes of Drugs that Mitigate Radiation Syndromes (2021) (2)
Interleukin-2-responsive wound-infiltrating lymphocytes in surgical adjuvant cancer immunotherapy. (1993) (2)
Characterization of Metastatic Tumor Formation by the Colony Size Distribution (2006) (2)
Biological Principles of Radiotherapy in the Central Nervous System (2003) (2)
Evaluation of 1,4,7-triazacyclononane-1,4-diacetate (NODA) ligand for the development of PET imaging agents (2011) (2)
Radiobiology of subclinical disease. (1994) (2)
The proteasome and radiation. (2005) (2)
Fighting disease with disease. (1998) (1)
HORMONE DEPRIVATION TREATMENT INDUCES SELECTIVE GROWTH OF SUPER AGGRESSIVE PROSTATE CANCER (CaP) CLONES (1999) (1)
Further studies on the serological effects of C. parvum immunotherapy in cancer patients. (1977) (1)
Abstract C227: Blockade of tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor overcomes tumor recurrence after radiation therapy. (2011) (1)
The effect of Corynebacterium parvum on T cell dependent tumor regression. (1980) (1)
Pretargeted immunoPET imaging of CEA-expressing tumors using a Ga-68 labeled peptide (2008) (1)
Weak Magnetic Fields Enhance the Efficacy of Radiation Therapy (2021) (1)
NRF2 Mediates Cellular Resistance to Transformation, Radiation, and Inflammation in Mice (2022) (1)
Phase I clinical study of pretargeted radioimmunotherapy (PRIT) in patients with colorectal cancer (CRC): An update (2012) (1)
Radiobiology, Principles of (2002) (1)
Screening for in vitro radiation protection and mitigation capacity of antimicrobial agents including those used in supportive care regimens for bone marrow transplant recipients (2015) (1)
The Proteasome in Cancer Biology and Therapy (2004) (1)
Effects of glucose and free fatty acid levels on in vitro 18F-FDG uptake in tumor cells (2011) (1)
Human glioma cell models resistant to alloreactive cytotoxic T lymphocytes (2004) (1)
Site-specific radiofluorination of biomolecules with Al18F-chelated prosthetic groups (2012) (1)
WR-2721 protects antitumor immune resistance against damage by whole body irradiation (WBI) and cyclophosphamide (CY) (1984) (1)
Prospective identification, tracking, and targeting of cancer-initiating cells in breast cancer and glioma via low proteasome activity (2008) (1)
Thymus-Derived T Cells SCID Mice Reconstituted with Mature , Generation of Intestinal Mucosal Lymphocytes in (1998) (1)
The Reticuloendothelial System: a Comprehensive Treatise: Vol. 5 'Cancer' (1984) (1)
Combining radiation therapy with IL-3 gene immunotherapy (2000) (0)
Abstract 3727: Overcoming of radiochemoresistance in glioblastoma stem cells via inhibition of lipid catabolism and SIRT1 deacetylase. (2013) (0)
Comment on double-strand break repair and rapamycin treatment. (2000) (0)
Nigella Sativa: Protecting the Oral Cavity During X-Irradiation in a Mouse Model (2018) (0)
A pretargeted bispecific PAM4-based antibody system for nuclear imaging and therapy of pancreatic cancer (2005) (0)
T cell receptor transgenic lymphocytes infiltrating murine tumors are not induced to express foxp 3 (2011) (0)
A Small Molecule Inhibitor of Protein Tyrosine Phosphatase-Sigma (PTPσ) Promotes Hematopoietic Stem Cell (HSC) Regeneration (2016) (0)
[Inflammatory and immune biomarkers of radiation response]. (2018) (0)
Radiation-Induced Vaccination to Breast Cancer (2015) (0)
Radioimmunoscintigraphy of colorectal cancer using a two-step pre-targeting method (2008) (0)
Abstract 1595: The poly(ADP-ribose) polymerase inhibitor BMN 673 has single agent activity and augments cytotoxicity of radiation in human head and neck tumor cell linein vitro: a novel strategy for radiosensitization in head and neck cancer. (2013) (0)
2029 Dose-response relationship of metastases: A mechanistic view based on a stochastic process of metastatic colony formation (1997) (0)
SOCS3 Regulates p21 Expression and Cell Cycle Arrest in Response to Radiation-induced DNA Damage (2008) (0)
Pretargeting B-cell lymphoma with recombinant bispecific antibodies (2007) (0)
288 A trivalent bispecific fusion protein produced in myeloma cells for improved pretargeting and therapy of CEA-expressing cancers (2004) (0)
Investigation of Radiation Therapy Response Enhancement of DC Magnetic Fields (2012) (0)
Immunotherapy in Combination With Radiation Therapy (2021) (0)
Host Resistance to Cancer (1986) (0)
Safety and efficacy of dendritic cell immunotherapy with ad-GMCAIX in an immunocompetent preclinical tumor model of renal cell carcinoma. (2012) (0)
Combining IL-3 gene immunotherapy with radiotherapy for prostate cancer (2004) (0)
Radiosensitization by High Affinity Programmable Minor Groove Binders (2013) (0)
Tolerance and adjuvant effects in mice (1971) (0)
Abstract B86: Radiation and TGFβ blockade bring back memories in metastatic breast cancer patients (2017) (0)
Bridged Analogues for p53-Dependent Cancer Therapy Obtained by S-Alkylation (2015) (0)
Ovarian Tumor Radiosensitivity Gene Increases p 53 Adenovirus-based Transfer of Wild-Type Updated Version (2006) (0)
AMP-activated protein kinase: a potential novel target for radiotherapy in prostate cancer (2007) (0)
Abstract #LB-159: MIS416: A second generation microparticle-based immune response modifier has broad spectrum anti-neoplastic activity in several pre-clinical mouse models (2009) (0)
A novel bispecific antibody (bsMAb) construct for nuclear imaging of pancreatic cancer (2007) (0)
VEGF Modulation by Radiation and Temozolomide in Glioblastoma Cells (2008) (0)
In vitro studies of ante-mortum proliferation kinetics (1986) (0)
Velcade ) with the Proteasome Inhibitor Bortezomib Dendritic Cell-Activated Immune Responses Immunosensitization of Tumor Cells to (2006) (0)
T Cell Responses to Alpha Fetoprotein-Derived Immunodominant Peptide-Pulsed Dendritic Cells in Patients with Hepatocellular Cancer (2004) (0)
Imaging of experimental prostate cancer with pretargeted immunoPET and FDG-PET (2012) (0)
DENDRITIC CELLS AND VACCINES Treatment ofMetastatic Colorectal Cancer Patients with a Tumor Lysate Pulsed Dendritic Cell Vaccine: A Randomized Evaluation of Ex Vivo CD40L Activation (2004) (0)
Targeting GRPR-expressing tumors with an 18F-labeled bombesin analog (2011) (0)
75 Enhancing the efficacy of radiation therapy in the treatment of local and micrometastatic prostate cancer through cytokine-mediated gene therapy (1999) (0)
An Ocular Photometric Method for Radiation Biodosimetry in Patients Following Whole Body Irradiation (2013) (0)
ET-60ENHANCED THERAPEUTIC EFFICACY OF PRODRUG ACTIVATOR GENE THERAPY WITH A NON-LYTIC RETROVIRAL REPLICATING VECTOR (TOCA 511) COMBINED WITH RADIATION THERAPY IN EXPERIMENTAL GLIOMA. (2014) (0)
Induction of Immunity Against Leukemia (1996) (0)
Assessment of hypoxia in colon adenocarcinomas using pimonidazole (2004) (0)
Abstract 3765: High-throughput RNAi screening identifies genes controlling glioblastoma stem cell migration and survival. (2013) (0)
A new lyophilized kit for 18F radiolabeling of peptides and temperature-sensitive biomolecules (2012) (0)
Pretargeting of prostate cancer with an internalizing anti-EGP-1 x anti-HSG bispecific antibody (2011) (0)
Sensitization of prostate cancer cells to radiation by the PI3 kinase inhibitor LY294002 and the proteasome inhibitor PS-341 (2007) (0)
Interleukin 32 expression in human melanoma (2019) (0)
Cancer esearch or and Stem Cell Biology R zing Radiation Activates the Nrf 2 Antioxidant Response (2010) (0)
Cyclooxygenase-2 (COX-2) predicts poor survival of T4 nasopharyngeal cancer patients treated by radiation therapy: Clinical and in vitro studies (2004) (0)
Flow cytometric dna analysis and its relevance to neoadjuvant therapy outcomes for soft tissue sarcomas (1994) (0)
In vitro and in vivo evaluation of FGFR as molecular target for rectal cancer radiosensitisation (2013) (0)
Noscapine Enhances Tumor Radioresponse in the GL261 Glioma Model: Implications for Glioma Therapy (2007) (0)
164 The wild type p53 gene radiosensitizes malignant cells and tumors (1996) (0)
304 DC-AD-GMCAIX BASED VACCINE THERAPY IS SAFE AND EFFECTIVE IN IMMUNOCOMPETENT MURINE KIDNEY CANCER TUMOR MODELS (2012) (0)
A new partial volume correction method for dynamic FDG images of heterogeneous tumor using factor analysis and stepwise procedure (2014) (0)
Adenovirus Lymphocytes by Dendritic Cells Transduced Generation of Melanoma-Specific Cytotoxic T (1998) (0)
Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide (2015) (0)
Enhancement of metastasis formation concomitant with granulocytosis in tumor-bearing mice. Abstr. (1983) (0)
Abstract 1410: Bmi-1 enhances the radioresistance of cells by suppressing the expression of NADPH oxidase genes (2010) (0)
SP-0537 TRANSLATIONAL STUDIES ON PRETARGETED RADIOIMMUNOTHERAPY OF COLORECTAL CANCER (2012) (0)
Lung cancer remains the leading cause of cancer-related death in North America and is a growing health crisis across the world . ” (2011) (0)
Position of lipidation influences anticancer activity of Smac analogs. (2019) (0)
INCREASEDPHAGOCYTICCELLACTIVITYAND ANAEMIA INCORYNEBACTERIUMPARVUM TREATEDMICE (1974) (0)
Using Megavoltage Cone Beam CT (MV CBCT) in Image-guided Radiation Therapy for Head and Neck Cancer (2009) (0)
Are colorectal adenocarcinomas hypoxic (2004) (0)
Lipid-conjugated Smac analogs (2015) (0)
PL-01A PRECLINICAL JUVENILE RAT MODEL OF BRAIN INJURY AFTER FRACTIONATED WHOLE BRAIN IRRADIATION (2014) (0)
Abstract 3308: Endothelin 3/endothelin receptor B signaling pathway blockade depletes radio-chemoresistant glioblastoma stem cells (2011) (0)
Bispecific antibody pretargeting of neovasculature for improved systemic radiotherapy of solid tumors in mice (2006) (0)
Regulation of immune responses to tumours and simple antigens (1987) (0)
RB-01A PRECLINICAL MODEL OF TRANSIENT EARLY-DELAYED RADIATION EFFECTS FOLLOWING WHOLE BRAIN IRRADIATION IN THE ADULT RAT (2014) (0)
Cellular interactions antibody in thymus-dependent responses (1982) (0)
157 The effect of cox-2 inhibition on molecular responses of rectal cancer to preoperative chemoradiation in a phase ii randomized, double blind, placebo-controlled clinical trial (2006) (0)
Shaping the Immune Landscape in Irradiated Breast Cancer Patients with Systemic TGF-β Blockade (2016) (0)
Low proteasome activity as a means to track and target breast cancer stem cells in-vivo. (2009) (0)
Abstract #2298: High throughput screening identifies two classes of antibiotics: tetracycline and fluoroquinolone eliciting radioprotection (2009) (0)
Recombinant bispecific antibodies (bsMAb) to carcinoembryonic antigen (CEA): Promising new agents for pretargeted radioimmunotherapy (RAIT) of solid tumors (2004) (0)
Hyperthermia inhibits 26s proteasome function and promotes androgen-independent growth of LnCaP prostate cancer cells (2001) (0)
Pretargeting a radiolabeled hapten peptide to pancreatic cancer with a novel bispecific antibody (bsMAb) (2007) (0)
Radiation-Induced Immune Modulation in Prostate Cancer (2007) (0)
Effect of Inter leukin 1 , Inflammation , and Surgery on the Incidence of Adhesion Formation and Death after Abdominal Irradiation in Mice 1 (2006) (0)
Radiation Effects on the Immune Response to Prostate Cancer (2008) (0)
Abstract 1795: Potent anti-tumor activity of talazoparib (BMN673) in combination with radiation for squamous cell carcinoma of the head and neck (2015) (0)
Fighting a Preventable Disease: Lung Cancer Diagnosis, Staging, and Treatment (2011) (0)
Prognostic indicators in node-negative breast cancer. (1990) (0)
What's new in photoimmunology? (2004) (0)
Pretargeted radioimmunotherapy of prostate cancer with an anti-TROP2 x anti-HSG bispecific antibody (2012) (0)
Regulation of the Response to Radiotherapy and Hyperthermia in Prostate Cancer by the 26s Proteasome (2002) (0)
Abstract 4987: Role of the PD-1/PDL-1 pathway in resistance of patients with metastatic breast cancer to treatment with radiotherapy and TGFβ neutralization (2016) (0)
Abstract 1563:In vivosafety and efficacy of a novel dendritic cell based Ad-GMCAIX vaccine with activity against renal cell carcinoma (2012) (0)
Cells in the Absence of CD8-Positive Cells Enhanced Tumor Responses to Dendritic (2013) (0)
BCN057, a Modulator of GSK3β, Induces KRAS G12D Mutant Pancreatic Cancer Cell Death (2021) (0)
The future of radiation therapy in the post-genomic era (2003) (0)

This paper list is powered by the following services:

William H. Mcbride's Academic­Influence.com Rankings

Why Is William H. Mcbride Influential?

William H. Mcbride's Published Works

Published Works

William H. Mcbride's AcademicInfluence.com Rankings